TMBRinactive

TREX WIND-DOWN, INC.

Healthcare·Immunology·Phase 3
ImmunologyDermatology

TREX WIND-DOWN, INC. (TMBR): 4 pipeline candidates · ~3 mo cash runway. Updated within the last hour.

6.6/10

BioSniper Score

4-factor signal · derived from public data

Cash Runway0.8

2.9 months

Financial Health9.9

D/E -2.27 · 1% dilution

Pipeline Maturity8.5

Lead: Phase 3

Pipeline Breadth7.2

4 candidates

Catalyst MomentumN/A

N/A

Insider SignalN/A

N/A

A transparent, data-derived signal for TREX WIND-DOWN, INC.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.

Key Financials

Market Cap

Cash

$2.5M

Quarterly Burn

$2.7M

Runway

2.9 mo

Revenue

$0

Cash Runway vs Catalysts

Tracked catalysts land within the current projected cash runway.

Cash ends ~Sep 2026
Today~7 mo out
Catalyst within runway

Pipeline (4 candidates)

Frequently asked questions

How many drug candidates are in TREX WIND-DOWN, INC.'s pipeline?

TREX WIND-DOWN, INC. (TMBR) has 4 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.

What is TREX WIND-DOWN, INC.'s lead drug candidate?

TREX WIND-DOWN, INC.'s most advanced tracked candidate is bpx-01 (Phase 3) for Inflammatory lesions of acne vulgaris.

What is TREX WIND-DOWN, INC.'s cash runway?

Based on its most recent reported cash balance and quarterly burn rate, TREX WIND-DOWN, INC. has approximately 2.9 months of cash runway.

Get the full picture on TREX WIND-DOWN, INC.

Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.